Business Context and Reporting Period
This Form 8-K Current Report from MacroGenics, Inc. covers events occurring on May 20, 2015, specifically the Company's 2015 Annual Meeting of Stockholders and subsequent Board actions regarding director compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses on corporate governance and compensation rather than financial performance.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting, with 24,643,369 shares present or represented by proxy (approximately 82.08% of outstanding shares).
- Proposal 1 (Director Election): Both Class II nominees, Kenneth Galbraith and David Stump, M.D., were elected.
- Proposal 2 (Auditor Ratification): The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2015 was approved.
Management Commentary and Compensation Changes
The Board approved a revised compensation program for non-employee directors, effective May 20, 2015. Key changes include:
- Annual Retainers: Base retainers range from $35,000 for Board members to additional amounts for committee service (e.g., $7,500 for Audit Committee members).
- Chairman Roles: Additional retainers are provided for committee chairs (e.g., $15,000 for Audit Committee Chair).
- Payment Options: Directors may elect to receive retainers in cash or stock options vesting monthly over 12 months.
- Stock Option Grants: New directors receive an initial option for 17,000 shares, while returning directors receive an annual option for 8,500 shares. Options vest monthly over 12 months.
Investor Verification Checklist
- Verify the total number of shares outstanding (30,023,734) as of the March 31, 2015 record date.
- Confirm the specific vesting schedule and exercise price for the new director stock options under the 2013 Stock Incentive Plan.
- Review the definitive proxy statement filed on April 9, 2015, for detailed biographies of the elected directors.
- Monitor future filings for the impact of the new compensation structure on the Company's stock-based expense.